http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10493164-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b54c936071b2b54f4b0c158e0917a890
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-0206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-0605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L79-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G73-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-58
filingDate 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a85d9e68103a71f382470cfb1d45851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85dde93c4239546e168aa2c7176f458c
publicationDate 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10493164-B2
titleOfInvention Method for preventing and treating adhesions
abstract The invention relates to inhibitory compounds of a p38 MAP kinase having a structure of type (I)-(VII) which can be used for the treatment or prophylaxis of adhesion. Pharmaceutical compositions are disclosed containing an effective amount of the substance SB203580 or one or more of the conjugated compounds of type (I)-(VII) or a combination thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient. Also disclosed is the use of the substance SB203580 as an agent having anti-adhesion activity. Also disclosed is a method for the prophylaxis and/or treatment of a disease or a condition in which there is a possibility of the formation and/or growth of adhesions, which makes it possible to dispense with the additional administration of a preparation in the post-operative period.
priorityDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004005264-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9503297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837719-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009103821-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0160868-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2363476-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291055-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457156385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448048434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457156382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456307405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457149144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157418824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466876654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457156384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447938305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426155993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456260132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159158871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457156383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157484788
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158486785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457149135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457149129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448023702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458087047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457149140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457149136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159627349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157130543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456228747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450283890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449359725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450935517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457149126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455555350

Total number of triples: 63.